- Filed
- Nov 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 4, 2025 | 5.92M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 2.64M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 1.27M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 55.83K sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 37.6K sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$6.3M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$14.57M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $12.71M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $6.5M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $11M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $3.83M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $2.88M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $4.71M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $2.67M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $1.14M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $9.47M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $6.65M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $1.85M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $1.91M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $1.85M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.91M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $12.83M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $6.57M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $12.86M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $6.62M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.77 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$9.76 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$40.15 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$354.05 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.77 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$9.76 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$40.15 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$354.05 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $1.02M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $3.4M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $965.71K |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $3.28M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $922.86K |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $3.1M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $830.98K |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $2.94M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$1.91M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$6.4M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$2.44M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$2.05M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$2.24M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$13.31M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$8.39M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$2.68M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$1.94M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$6.5M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$1.8M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$6.22M |
| Capex | Q3 2025 · Sep 30, 2024 | $36.86K |